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Biopharmaceutical proteins are often formulated and freeze dried in agents that protect
them from deleterious reactions that can compromise activity and authenticity. Although
such approaches are widely used, a detailed understanding of the molecular mechanisms of
protein stabilization in low water content amorphous glasses is lacking. Further, whilst dete-
rioration chemistries are well described in dilute solution, relatively little is known about
the extent and mechanisms by which protein integrity is compromised in the glassy state.
Here we have investigated the relationship between protein modification and rate thereof,
with variation of pH, carbohydrate excipient, temperature and the glass transition tempera-
ture using a model protein, lysozyme. Mass spectrometry analysis and peptide mapping con-
firm that protein modifications do occur in the glassy state in a time-, temperature-, and
carbohydrate excipient-dependent manner. There were clear trends between the buffer pH
and the primary modification detected (glycation). Most importantly, there were differences
in the apparent reactivities of the lysine residues in the glass compared with those previ-
ously determined in solution, and therefore, the well-characterized solution reactivity of this
reaction cannot be used to predict likely sites of modification in the glassy state. These find-
ings have implications for (i) the selection and combinations of formulation components,
particularly with regard to glycation in the glassy state, and (ii) the design of procedures
and methodologies for the improvement of protein stability in the glassy state. VC 2009
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Introduction
In the in vivo, environment, proteins are sensitive to a
number of well-characterized rearrangements, degradations,
and chemical reactions that compromise the integrity of
these proteins (e.g., the Maillard reaction, deamidation, and
oxidation) and lead or contribute toward the progression of
various disease states.1 Animal species (in addition to others)
have, therefore, developed protective mechanisms to either
prevent or reverse these damaging reactions, or alternatively
to remove and degrade such modified proteins. Such modi-
fications are also observed in proteins in vitro, however,
additional degradations and rearrangements are also often
observed in solution including hydrolysis (particularly at
Asp-Pro motifs), disulphide cross-linking and diketopipera-
zine formation,2 all of which can result in the damaging loss
of protein integrity, decreased or abolished bioactivity, and
increased immunogenicity.3,4
There is, thus, an industrial requirement to prevent such
modifications in vitro and preserve the integrity of proteins
and peptides in both the food and biopharmaceutical sectors
prior to their consumption or use to maintain biological au-
thenticity. With particular regard to the biopharmaceutical
industry, this is usually achieved via a range of strategies
that involve formulating the protein of interest with protect-
ing agents or excipients that protect the protein from delete-
rious reactions that might otherwise compromise their
activity and authenticity.5,6 Often these strategies have been
optimized using empirical approaches.7
One standard practice/strategy utilized in both the food and
biopharmaceutical fields is that of putting the protein/peptide of
interest into the glassy state.8,9 Practically this involves drying
a peptide or protein, often with other glass-forming compo-
nents, which are typically low molecular weight carbohy-
drates.10 Drying is achieved by processes such as spray drying
or freeze-drying. The mechanism by which this strategy pre-
vents modification is thought to be the result of vitrification of
the protein–carbohydrate mixture which, during freeze-drying,
allows the formation of a readily dried open-pored cake11 and
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subsequently, during storage, retards molecular motion and
arrests chemical reaction on a practical timescale. A further
application of the glassy state is protein stabilization during
antiviral dry heat treatments. For example, freeze-dried Factor
VIII is routinely treated at 80C for 72 h, conditions that would
result in rapid deterioration of the protein in the solution state,
however, in the glassy state the protein is protected and virus
inactivated. Indeed, we have previously shown that during anti-
viral dry heat treatment protein modification can occur to pro-
tein samples following freeze-drying.12
Although proteins dried in the absence of any additives form
glasses,13 those with added carbohydrate have been shown to
have enhanced stability.14 It has been proposed that the role of
the carbohydrate is that of water replacement.14 This is both in
a general sense, that is, not only by filling the space which
would be occupied by the water in the hydrated system, reduc-
ing the extent to which the secondary and tertiary structures of
the protein are modified on drying, but also through a more
specific interaction of the carbohydrate, particularly the disac-
charide trehalose, with the protein which enhances stability.
Although there is a relatively large body of empirical
work on how formulation and storage temperature affects the
rates at which proteins in the glassy state either aggregate or
lose their biological activity,5 and there are several studies
investigating such changes in the glassy state15,16 our under-
standing of the molecular mechanisms of protein stabiliza-
tion in glasses in the biotechnological setting is still far from
complete. Further, while the deterioration chemistries are
well described in dilute solution, relatively little is known
about the extent and mechanisms by which protein (and
peptide) integrity is maintained, or indeed compromised, by
glassy state stabilization technologies.17 Particularly at
higher temperatures, protein unfolding may facilitate decom-
position by new pathways, an area relevant to antiviral dry
heat treatments of protein preparations. Although carbohy-
drate additives have been used to promote thermal stability
of proteins, their molecular mechanism remains poorly
understood and the potential to control the deterioration
chemistry has not been exploited. Furthermore, a better
understanding of the relationship between water content,
temperature, formulation/carbohydrate excipient, and pro-
tein stability will help in the rational development of
formulations that prevent or limit such potentially damaging
reactions for the improved stability of food and biopharma-
ceutical products.18,19
The aim of this study was to address this gap in our
knowledge using the model protein hen egg white lysozyme
to investigate the relationship between chemical modification
and rate thereof, pH, carbohydrate excipient, temperature,
and the glass transition temperature. Mass spectrometry anal-
ysis and peptide mapping confirm that protein modifications
do occur in the glassy state in a time-, temperature-, carbo-
hydrate-, and pH-dependent manner. These findings have
implications for (i) the selection and combinations of formu-
lation components, and (ii) the design of procedures and
methodologies for the improvement of protein stability in the
glassy state to assure protein product quality.
Materials and Methods
Materials
All materials were of analytical reagent grade or better
and purchased from Sigma Aldrich unless otherwise stated.
Dextran (molecular weight 40,000) was sourced from Fluka.
Commercial hen egg white lysozyme was sourced from
Sigma and was of Grade 1 (provided three times recrystal-
lized and lyophilized by the manufacturer).
Preparation of samples and formulations for freeze-drying
Protein formulations consisting of 5 mg/mL lysozyme
were prepared with industrially relevant 3% sucrose, treha-
lose, and dextran excipients at pH 6.2, 7.2, or 8.2. To pre-
pare the final solutions ready for freeze-drying, the required
amount of excipient was dissolved separately in preprepared
0.1M sodium phosphate buffer pH 6.2, 7.2, or 8.2 containing
5 mg/mL lysozyme. The resulting protein solutions were
then filtered, sterilized, and stored frozen (20C) prior to
freeze-drying.
Freeze-drying of samples
Aliquots (1 mL) of the appropriate protein formulation
(prepared as described above) were pipetted into 2 mL vials
(Adelphi, Haywards Heath, UK) with a predried slotted stop-
per. The vials were then loaded onto a stainless steel tray
and freeze-dried using a Virtis Advantage (EL 2.0) freeze-
dryer (Biopharma Process Systems, Winchester, UK) using
the following conditions: freeze the samples until shelf tem-
perature reaches 45C; hold the samples at this temperature
for at least 60 min; primary dry at 35C for 40 h; second-
ary dry at temperatures rising from 35 to 10C at 100
mTorr over a period of 66 h before increasing the tempera-
ture to 20C at 70 mTorr for a further 45 h. This protocol
was developed based upon the glass transition behavior of a
frozen sucrose-rich system. Often the freeze dryer would be
loaded with samples with very different drying characteris-
tics and so a slow drying protocol to accommodate all was
used. Vials were then vaccuum dried in a vacuum oven over
phosphorus pentoxide for 5 days. Finally, the vials contain-
ing the freeze-dried material were closed with a stopper and
capped with aluminum caps. The amorphous nature of the
samples was confirmed by the absence of crystals when
viewed using polarizing light microscopy.
Determination of glass transition temperature and water
content in freeze-dried samples
Glass transition temperatures (Tg) of freeze-dried samples
were determined in triplicate after panning in a glove box
under dry nitrogen conditions using a Perkin Elmer DSC 7
differential scanning calorimeter. An initial scan was per-
formed to remove any effects of physical aging of the
samples which can affect the apparent glass transition tem-
peratures.20,21 Tg’s were determined on a rescan at a scan-
ning rate of 10C/min as described previously.20,21 One
exception to the use of this method was the sucrose pH 6.2
samples which were highly susceptible to buffer crystalliza-
tion and so in this case the Tg was estimated from the first
scan. A baseline was subtracted from the scan before analy-
sis. The midpoint transition is quoted as determined by Wun-
derlich.22 The water content of samples was determined in
the differential scanning calorimeter (DSC) pans by punctur-
ing the pan with a needle and then drying them to a constant
weight (as determined using a Mettler ME30 balance) in a
evacuated vacuum oven at 60C over phosphorus pentoxide.
After drying samples were cooled in a dessicator to room
temperature before measurement.
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Stability studies following freeze-drying of lysozyme in
various excipient formulations
Following freeze-drying, all samples were stored in sealed
vials at 80C until analyzed or used for stability testing.
For stability testing and accelerated storage studies the vials
containing 1 mL aliquots of freeze-dried material were
stored and incubated at either 80C (control), ambient tem-
perature (18–20C), 37, 55, or 90C for either 24 h, 1 month,
or 16 months, prior to analysis as detailed later. Visual
inspection of samples was undertaken immediately after stor-
age and the details recorded. For more detailed molecular
analysis, samples were reconstituted in the vial by reconstitu-
tion in 1 mL of ddH2O.
Measurement of lysozyme activity
Lysozyme activity was determined by measuring the rate
at which a known concentration of enzyme cleared a solu-
tion of the bacterial substrate Micrococcus lysodeikticus.
Briefly, a 0.5 mg/mL suspension of Micrococcus lysodeikti-
cus was prepared in PBS (pH 6.5) and stored on ice. This
suspension was sonicated regularly and frequently to prevent
aggregation or clumping of the cells. Reconstituted lysozyme
solutions (20 lL) were then added to 1 mL of the substrate
solution and the absorbance recorded every 10 s at 500 nm
until a constant reading was obtained. All samples were ana-
lyzed in triplicate and the initial rate of clearance calculated
to determine the lytic activity of the lysozyme sample in
absorbance units/sec.
Electrospray ionization mass spectrometry analysis of
lysozyme following freeze-drying and stability testing
Mass spectra were recorded in the positive ion mode on a
Finnigan MAT LCQ ion trap mass spectrometer and the
charge state ion distributions observed in ESI mass spectra
deconvoluted as previously described12 except that deconvo-
lution was achieved using Excalibur software (version 1.2).
Excipients were removed by reverse-phase high-performance
liquid chromatography (HPLC) using a C18 reverse-phase
column (250  2.0 mm2 i.d., Phenomenex Jupiter, Maccles-
field, Cheshire, UK) linked to an Agilent 1100 LC system
before the sample was introduced into the mass spectrometer
as previously described.12
Tryptic peptide mapping
Reconstituted lysozyme samples were reduced and alky-
lated with iodoacetic acid essentially as described by Smales
et al.12 Samples were dialyzed against 8M urea, 0.25M Tris-
HCl buffer (pH 8.75) containing 1 mM EDTA and then 2.16
lmol dithiothreitol in 100 lL of the same buffer was added
per 2 mg of lysozyme. The resulting solution was then left
to incubate at 37C for 3 h prior to the addition of iodoacetic
acid (3 lL of a 2M solution per 2 mg of lysozyme). Alkyla-
tion was then allowed to proceed in the dark at room tem-
perature for 45 min. b-mercaptoethanol was finally added
(1% v/v) and the alkylated protein dialyzed against 8M urea.
After dialysis, the alkylated protein solutions were diluted
with 1% ammonium bicarbonate buffer to give 2M urea sol-
utions. TPCK treated trypsin solution (4M in H2O, 0.05%
TFA) was then added to the digest solution so that an enzy-
me:substrate ratio of 1.5:100 (w/w) was achieved. The mix-
ture was then left to digest for 5.5 h at 37C before being
stored at 20C until required for further analysis.
Separation of the resulting tryptic fragments was carried
out on a C18 reverse-phase column (Phenomenex Jupiter,
250  2.0 mm2 i.d.) using an Agilent 1100 LC system. Ali-
quots from tryptic digests were loaded onto the column pree-
quilibrated with deionized water (containing 0.05% TFA)
and then eluted using a gradient from 0 to 70% acetonitrile
(containing 0.045% TFA) in 100 min at a flow rate of 0.2
mL/min. Upon elution the peptides were introduced into a
Finnigan MAT LCQ ion trap mass spectrometer and mass
spectra recorded in the positive ion mode. The instrument
was also setup to collect ms/ms spectra of all peptide peaks
so that sequence information could be obtained in addition
to peptide mass data. The charge-state ion distributions
observed in electrospray ionization mass spectra were ana-
lyzed using Excalibur software (version 1.2).
Results
The physical appearance of lysozyme samples changes
after freeze-drying and storage
Lysozyme is a protein that is readily obtained in large
amounts, relatively small (14,306 Da) and thus highly ame-
nable to analysis by mass spectrometry, and possesses an en-
zymatic activity that can be quickly, easily and cheaply
determined. Further, this small enzyme has been extensively
characterized and would therefore appear to be an ideal
model protein with which to investigate a wide range of for-
mulation and storage conditions as described in this work.
The physical appearance of the protein samples after
freeze-drying was a white cake tightly filling approximately
10 mm at the bottom of the vial. The dextran samples
appeared more finely textured than the sucrose and trehalose
formulated samples (Table 1). Following storage at all times
and temperatures investigated in this study, the dextran sam-
ples, irrespective of pH, exhibited little difference in appear-
ance apart from a slight shrinkage in the volume (Table 1).
With longer and higher temperature storage conditions how-
ever, the dextran samples took longer to reconstitute after
addition of 1 mL of water (data not shown). The time taken
for complete reconstitution was as long as 15 min which
would be unacceptable in the medical setting. The trehalose
samples also showed very little change in appearance after
storage, the exception being the samples formulated at pH
6.2 and stored for 24 h at 90C. This combination of carbo-
hydrate and temperature exhibited marked shrinkage as com-
pared with other trehalose samples; however there was no
change in the ease with which these samples were reconsti-
tuted. In contrast, sucrose formulated samples showed more
extreme change in appearance (Table 1). This was particu-
larly noticeable for the sample formulated at pH 6.2 and
stored at elevated temperatures. The sample stored at 90C
for 24 h was a hard brown mass at the bottom of the vial
and was extremely difficult to redissolve. The sucrose sam-
ples formulated at pH 7.2 or pH 8.2 did not exhibit large
changes in physical appearance and reconstituted with ease.
Glass transition temperatures (Tg) and water content
following freeze-drying
Typical DSC scans showing heat flow per unit mass as a
function of temperature are shown in Figure 1. All the sam-
ples with the exception of the sucrose pH 6.2 samples were
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stable with respect to buffer crystallization when heated
above their glass transition temperature. For all such samples
a second scan was performed thus removing the effects of
physical aging on the scans which can affect the results (20).
In the unique case of the sucrose pH 6.2 samples a Tg deter-
mined from the first scan as in Figure 1 is reported. All the
formulations were glassy at ambient temperatures with glass
transition temperatures varying in the range 37.7C for the
pH 6.2 sucrose formulation to 187.0oC for the pH 8.2 dex-
tran formulation as shown in Table 2. The water contents
were low and varied in the range 1.0–3.0% w/w (Table 2).
The range of glass transition temperatures means that during
incubation in the stability studies the physical state of the
samples varied from being wholly in the glass state (dextran
samples), largely in the glass state (trehalose samples at
90C are in a viscous liquid state above their glass transition
temperature but all other samples are in the glass state) to




Initial Rate (D OD/sec)
Time Temp Mean SD
Sucrose 6.2 control 80 White, lacy 0.067 0.004
7.2 control 80 White, slightly shrunken 0.078 0.002
8.2 control 80 White, slightly shrunken 0.076 0.002
Trehalose 6.2 control 80 White, slightly shrunken 0.075 0.002
8.2 control 80 White, slightly shrunken 0.077 0.003
Dextran 7.2 control 80 White, slightly shrunken 0.084 0.001
8.2 control 80 White, slightly shrunken 0.093 0.001
Sucrose 6.2 24 h 90C Brown, small, hard 0.055 0.013
7.2 24 h 90C White, small 0.105 0.004
8.2 24 h 90C White, shrunken 0.089 0.008
Trehalose 6.2 24 h 90C White, shrunken 0.074 0.015
7.2 24 h 90C White, slightly shrunken 0.115 0.003
8.2 24 h 90C White, slightly shrunken 0.102 0.000
Dextran 6.2 24 h 90C White, slightly shrunken 0.068 0.001
7.2 24 h 90C White, slightly shrunken 0.086 0.001
8.2 24 h 90C White, slightly shrunken 0.072 0.009
Sucrose 6.2 1 month 55C Brown, small, hard 0.072 0.001
7.2 1 month 55C White, slightly shrunken 0.076 0.001
8.2 1 month 55C White, slightly shrunken 0.076 0.001
Trehalose 6.2 1 month 55C White, slightly shrunken 0.073 0.001
7.2 1 month 55C White, slightly shrunken 0.075 0.001
8.2 1 month 55C White, slightly shrunken 0.078 0.001
Dextran 6.2 1 month 55C White, slightly shrunken 0.075 0.002
7.2 1 month 55C White, slightly shrunken 0.085 0.002
8.2 1 month 55C White, slightly shrunken 0.078 0.002
Sucrose 6.2 16 month 37C Off white, small 0.094 0.003
7.2 16 month 37C White, slightly shrunken 0.097 0.001
8.2 16 month 37C White, slightly shrunken 0.091 0.006
Trehalose 6.2 16 month 37C White, slightly shrunken 0.074 0.003
7.2 16 month 37C White, slightly shrunken 0.075 0.004
8.2 16 month 37C White, slightly shrunken 0.072 0.002
Dextran 6.2 16 month 37C White, slightly shrunken 0.071 0.007
7.2 16 month 37C White, slightly shrunken 0.085 0.000
8.2 16 month 37C White, slightly shrunken 0.082 0.001
Lysozyme samples were freeze-dried in pH 6.2, 7.2 or 8.2 buffer containing 3% sucrose, trehalose or dextran prior to incubation (sd, standard
deviation).
Figure 1. Differential scanning calorimeter (DSC) scans of
amorphous lysozyme-carbohydrate pH 6.2 phosphate
buffer mixtures to determine their glass transition
temperatures (Tgs).
(1) Sucrose formulation first scan showing (A) enthalpy relaxa-
tion peak, and (B) the onset of an endothermic (buffer) crystal-
lisation peak. (2) Trehalose formulation, rescan. (3) Dextran
formulation, rescan. For further details see text.
Table 2. Glass transition temperature and water content of
freeze-dried lysozyme-carbohydrate-phosphate buffer formulations
Carbohydrate pH* Tg (
C) Water Content (% w/w)
Sucrose 6.2 37.7 1.0
7.2 75.4 2.6
8.2 87.3 2.5
Trehalose 6.2 61.0 1.0
7.2 69.7 1.7
8.2 74.7 1.2
Dextran 6.2 172.0 2.8
7.2 182.1 2.4
8.2 187.0 3.0
Prior to freeze-drying each sample contained 5 mg/mL lysozyme, 3%
w/w carbohydrate and 0.1 M sodium phosphate buffer. pH refers to
value prior to freeze-drying.
*Refers to pH upon formulation and not in the glassy state.
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being in both viscous liquid and glass states (pH 6.2 sucrose
samples at 37C are in the glass transition region and at
higher temperatures are in the viscous liquid states whereas
the pH 7.2 and 8.2 samples are only in the viscous liquid
states at 90C). It should be noted that the Tgs are the initial
Tgs before significant reaction/protein modification has
occurred. The glycation reaction produces water as the reac-
tion proceeds and the water content therefore increases
which would be expected to depress the Tg.
23
The effect of glass formulation variables and storage
conditions upon enzymatic activity
The lytic activity of lysozyme for the bacterial substrate
Micrococcus lysodieticus was used to determine if the enzy-
matic activity of lysozyme samples was preserved or
degraded more efficiently/rapidly under any of the formula-
tion and storage conditions investigated. For this analysis all
activities were determined in triplicate and the average is
shown in Table 1. As it can be observed from the resulting
initial rates calculated and presented in Table 1, there was
very little variation in the initial rate at which lysozyme
cleared a solution of the bacterial substrate with changing
formulation and storage conditions. The largest difference
was observed when lysozyme was freeze-dried in sucrose
formulated at pH 6.2 and stored at 90C for 24 h where the
initial rate was much lower than that for the other two pH’s
(Table 1). This trend of the lowest initial rate being observed
in samples formulated at pH 6.2 when compared with those
formulated at pH 7.2 or pH 8.2 was consistently observed
across the majority of storage conditions (Table 1). As such,
the data suggest that preformulation of lysozyme at pH 6.2
is likely to result in the greater relative loss of enzymatic ac-
tivity regardless of the carbohydrate in the formulation. Fur-
ther, the data show that lysozyme is a very robust enzyme
that retains its activity under a wide range of conditions,
even in samples that physically appear modified and there-
fore may not be the best choice for studying effects on enzy-
matic activity under such conditions.
Direct ESI mass spectrometry analysis of lysozyme samples
confirms chemical modification under certain conditions
Direct ESI mass spectrometry analysis was undertaken on
lysozyme samples upon freeze-drying and storage to deter-
mine the extent of any chemical modifications resulting in
mass change. As shown in Figure 2A, LC-ESI-MS analysis
of a lysozyme sample freeze-dried in sucrose at pH 6.2 prior
to storage (time ¼ 0) gave a single peak with a molecular
mass of 14,303.9 Da in agreement with the theoretically cal-
culated mass for intact lysozyme. Subsequent analysis of ly-
sozyme freeze-dried in sucrose formulated at pH 6.2, 7.2,
and 8.2 and stored at 55C for 1 month showed obvious
chemical modification to some of the protein material (Fig-
ures 2B–D). The deconvoluted spectrum of lysozyme sam-
ples formulated at pH 6.2 and incubated at 55C contained
four well-defined extra peaks observed at 14,467, 14,629,
14,793, and 14,955 Da, respectively (Figure 2B, Table 3)
corresponding to increases in mass of multiples of 162 Da.
This mass change can be assigned to protein modification
resulting from the condensation of one unit of glucose or
fructose with the amino group of a lysine residue on the sur-
face of the protein. This nonenzymatic process termed pro-
tein glycation24,25 is possible because of the hydrolysis of
sucrose to yield fructose and glucose.26 In addition to these
well defined peaks, there were other less well-defined peaks/
Figure 2. Electrospray ionization mass spectrometry analysis of lysozyme samples formulated in sucrose after freeze-drying and stor-
age for 1 month at 558C.
(A) Lysozyme formulated at pH 6.2 at time ¼ 0 (control sample), (B) lysozyme formulated at pH 6.2 after 1 month at 55oC, (C) lysozyme formu-
lated at pH 7.2 after 1 month at 55oC, (D) lysozyme formulated at pH 8.2 after 1 month at 55oC.
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areas within the spectrum indicative of additional chemical
modifications or rearrangements that had occurred, but it
was not possible to assign these from this data. It is likely
that some of these products arise from rearrangement of the
glycation adducts to yield advanced glycation end products
(AGEs).
Mass spectrometry analysis of lysozyme samples freeze-
dried in sucrose at pH 7.2 and subsequently stored at 55oC
for 1 month showed less chemical modification than that
observed at pH 6.2 with only two of these extra peaks pres-
ent in the deconvoluted spectra; those at 14,467 and 14,632
Da, respectively (Figure 2C). The extent of chemical modifi-
cation was even less in those samples formulated before
freeze-drying in sucrose at pH 8.2 with just one of these
major additional peaks being observed, that at 14,466 Da,
suggesting that less glycation occurs under these conditions.
A clear relationship between the pH before freeze-drying
and protein glycation was therefore apparent. We note that
the glycation of proteins can suppress or change its ioniza-
tion behavior, therefore, although the relative levels of gly-
cated and nonglycated material cannot be calculated from
these data, the relative levels of each glycated product can
be directly compared and thus allows the comparisons and
conclusions drawn above to be made.
When sucrose formulated samples were stored at lower
temperatures but for longer periods of time a similar trend
was observed (Figure 3). Sucrose samples stored at 37C for
16 months after formulation at pH 6.2 prior to freeze-drying
once again showed chemical modification of up to 4 discrete
higher masses; 14,466, 14,629.5, 14,791.2, and 14,955.5 Da
corresponding to glycation events (Figure 3A). In addition,
various other species were once again present and detectable
between the unmodified protein (14,304.7 Da) and the peaks
at 14,466 and 14,629.5 Da (Figure 3A), indicative of further
undefined modifications occurring. Despite these changes,
the lytic activity of such samples was not changed compared
with those formulated at pH 7.2 or pH 8.2 (Table 1) where
there was little evidence of modification. For samples formu-
lated in sucrose at pH 7.2 prior to freeze-drying and storage
for 16 months at 37C only one of the glycation peaks was
detected (14,465.2 Da) along with a small amount of other
modified material between this and the unmodified peak
Figure 3. Electrospray ionization mass spectrometry analysis of lysozyme samples formulated in sucrose after freeze-drying and stor-
age at various times and temperatures.
(A) lysozyme formulated at pH 6.2 after 16 months at 37oC, (B) lysozyme formulated at pH 7.2 after 16 months at 37oC, (C) lysozyme formulated
at pH 8.2 after 16 months at 37oC, (D) lysozyme formulated at pH 6.2 after 24 h at 90oC.
Table 3. LC-MS Determined Masses of Lysozyme Samples After






6.2 Sucrose 14304.7 Lysozyme
14467.4 162.7 1  glycation
14629.0 324.3 2  glycation
14793.0 488.3 3  glycation
14955.7 651 4  glycation
15098.2 793.5 5  glycation
7.2 Sucrose 14305.4 Lysozyme
14467.4 162 1  glycation
14632.0 326.6 2  glycation
8.2 Sucrose 14304.4 Lysozyme
14465.9 161.5 1  glycation
6.2 Trehalose 14304.7 Lysozyme
1  glycation
14630.2 325.5 2  glycation
7.2 Trehalose 14304.5 Lysozyme
8.2 Trehalose 14304.4 Lysozyme
6.2 Dextran 14303.6 Lysozyme
7.2 Dextran 14304.0 Lysozyme
8.2 Dextran 14304.4 Lysozyme
Lysozyme samples were freeze-dried in pH 6.2, 7.2 or 8.2 buffer con-
taining 3% sucrose, trehalose or dextran.
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(Figure 3B). A similar profile to that of the pH 7.2 samples
was observed in those samples formulated in sucrose at pH
8.2 prior to freeze-drying and storage at 37oC for 16 months
(Figure 3C).
In contrast to the previous results, when samples formulated
in sucrose at pH 6.2 prior to freeze-drying were stored at
90oC for 24 h the spectra was highly variable and the main
peak was observed as a broad peak at or around 15,000 Da in-
dicative of the protein being modified to different degrees and
with varying modifications (Figure 3D). It was not possible to
assign any of the potential modifications from this data. Inter-
estingly, in this sample there appears to be a further broad
peak centered just below 13,000 Da suggesting degradation of
some of the material in addition to those chemical modifica-
tions leading to an increase in the observed mass (Figure 3D).
This agrees with the enzymatic data whereby the lytic activity
of this sample was reduced compared with the samples at
90C for 24 h formulated at pH 7.2 or 8.2 (Table 1). Together,
these results confirm that the temperatures and times investi-
gated are sufficient for accelerated stability studies in order to
‘‘force’’ modifications. We also note that these temperatures
are used routinely within industry for such investigations.
When lysozyme was freeze-dried using trehalose as the
carbohydrate and then subjected to accelerated stability stud-
ies, there was little evidence by intact mass spectrometry
that chemical modification or loss of protein integrity had
occurred under any of the conditions investigated (Table 3).
Only those samples formulated in trehalose at pH 6.2 prior
to freeze-drying and then stored subsequently at 90C for
24 h showed readily observable, but still minor, degrees of
chemical modification. This agrees with the enzymatic activ-
ity data whereby comparison of the trehalose samples stored
at 90C showed that those formulated at pH 6.2 had signifi-
cantly lower enzymatic activity than those at 7.2 or 8.2 (Ta-
ble 1). The deconvoluted spectra of samples freeze-dried and
stored in this way showed one defined additional peak
(14,628.5 Da) along with a small amount of material indica-
tive of other chemical modification. Formulation at higher
pH or more extreme storage conditions resulted in little de-
tectable modification. For all dextran samples, there was no
evidence of chemical modification under any of the condi-
tions investigated.
Tryptic mapping confirms glycation and deamidation are
the major chemical modifications to lysozyme under the
freeze-dried conditions investigated
Mass spectrometry analysis of lysozyme samples follow-
ing freeze-drying and storage showed conclusively that time,
temperature and formulation variables determined the extent,
and type, of chemical modification observed. However,
although such analysis can confirm the presence of chemical
modification it does not allow identification of which amino
acids are modified within the protein, or the unambiguous
assignment of small mass change modifications such as dea-
midation. Lysozyme samples that had been freeze-dried and
stored at 55C for 1 month were therefore subjected to tryp-
tic peptide mapping in order to determine which amino acid
residues were modified and to more fully characterize the
observed modifications. The resulting tryptic peptides were
then separated by reverse phase HPLC and ESI mass spec-
trometry (Figure 4 and Table 4).
The expected tryptic peptides from lysozyme were initially
identified from their masses and later confirmed by tandem
mass spectrometry analysis (Table 4 and Figure 4). Confir-
mation of glycation, and therefore the glycated lysine resi-
due, was relatively straightforward as trypsin does not cleave
after glycated lysine residues and therefore glycated peptides
contain an uncleaved lysine residue.27 In addition to an
uncleaved lysine residue, glycated peptides are detected in
the mass spectrometer as 162 Da greater in mass than would
be expected in the absence of glycation due to the presence
of the sugar residue. Modifications and their site(s) were also
confirmed by tandem mass spectrometry analysis.
Glycation was observed at all six lysine (K ¼ lysine) resi-
dues within lysozyme during this study when samples were
formulated in sucrose (Table 4). Most glycation was
observed at lysine residues 96 and 33 as determined from
the HPLC UV traces (Figure 4). The extent of glycation var-
ied with the formulation, with samples formulated at pH 6.2
in sucrose prior to freeze-drying giving rise to the greatest
extent of modification. In samples treated in this manner 3
of the glycation sites, K33 in peptide T6þT7, K97 in
T12þT13, and K116 in T15þT16 were visible as extra peaks
in the UV traces (Figure 4). Whilst the other three glycation
sites detected did not give rise to new, clearly visible peaks
in the UV spectra, these were clearly present when the mass
spectra data was analyzed in detail, suggesting that these
sites are less susceptible to protein glycation. With increas-
ing pH, fewer lysines were glycated and the peaks for those
that were detected appeared smaller than the corresponding
peaks observed in the pH 6.2 samples (Figure 4). As
expected, there was much less evidence of protein glycation
in trehalose formulated freeze-dried samples agreeing with
the data for the intact protein (Table 4). Further, as expected
there was no evidence of glycation in dextran samples in
agreement with data from the intact protein mass spectrome-
try analysis (Table 4).
The tryptic mapping and ms/ms analysis also revealed that
deamidation had occurred to lysozyme samples. Deamidation
of N103 was observed in all samples (peaks 7h and 7j, Figure
4) and has previously been observed in control samples in
other studies suggesting that this is not related to the freeze-
drying or formulation variables investigated in this study.13
However, there was an additional deamidation peak corre-
sponding to N103 which was only detected in samples formu-
lated in sucrose at pH 6.2 prior to freeze-drying (Table 4).
There was no evidence of other commonly observed modifi-
cations such as methionine oxidation, however, there were
peptide peaks and masses within these spectra which we
were not able to assign on the basis of mass alone and the
appearance of several of these did exhibit formulation de-
pendent tendencies suggesting that additional, but as yet
uncharacterized modifications, do arise under the variables
investigated.
Discussion
The integrity of protein based products such as biothera-
peutic pharmaceuticals (e.g. monoclonal antibodies) must be
preserved prior to administration in order to prevent immu-
nogenicity and maintain bioactivity. Similarly, the structure
of proteins in food ingredients must be maintained in order
to retain their functionality prior to use. Plant anhydrobiotes
can preserve biological activity of proteins by accumulating
sugars in their tissues during drying and transforming the
cytoplasm into a glassy state.28 A similar approach has been
applied to the stabilization of high-value therapeutic proteins
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whereby they are preserved in the glassy state following
freeze-drying in a carbohydrate based formulation.18 There
has been considerable work undertaken on how formulation
and storage temperature of protein glasses affects the rates at
which proteins aggregate or lose their biological activity;
however, our understanding of the molecular mechanisms of
protein stabilization and chemical modification in glasses is
incomplete. We, therefore, investigated the relationship
between chemical modification and rate thereof with varia-
tion of pH, temperature, and the glass transition temperature
using the most commonly used carbohydrate additive for the
formation of mixed protein–carbohydrate glasses (sucrose) as
well as trehalose and dextran to further our understanding of
the mechanisms and processes involved.
The glass transition temperature of these mixed formula-
tions depends upon all the compositional variables i.e., the
amount of carbohydrate, monosodium phosphate, disodium
hydrogen phosphate, lysozyme, and water. The relative
amount of the phosphate salts depends upon the buffer’s pH.
Whilst the present dataset is insufficiently large to distin-
guish effects of all the variables there was a clear difference
between the Tg of the disaccharide-based formulations (su-
crose, trehalose) and the higher molecular weight polysac-
charide-based formulations (dextran) which reflects the
higher glass transition temperature of the polysaccharide ex-
cipient in its pure dry amorphous form which has been
reported as 189C for dextran29 when compared with 67 and
111C for sucrose30 and trehalose31 respectively. The sodium
phosphate buffer, water content and the protein itself have
secondary effects on the Tg of the freeze-dried formulations.
The Tg’s of all the formulations increase with pH in agree-
ment with data reported by Ohtake et al.32 who reported that
sucrose- and trehalose-phosphate buffer formulations dried
from higher pH (richer in disodium hydrogen phosphate)
have higher Tg
0s. We note that the relatively low Tg of the
sucrose pH 6.2 formulation has a composition which is in
the vicinity of a phase separation32 and that in samples for-
mulated at pH 7.2 and 8.2 the Tg’s of sucrose were higher
than those of trehalose, reversing the relationship between
these observed at pH 6.2. The pH 7.2 and 8.2 sucrose formu-
lations have Tg’s above that of pure dry sucrose indicating a
positive contribution of the buffer and protein to the overall
glass transition temperature of the mixture despite the pres-
ence of water which generally acts as a plasticiser, depress-
ing the glass transition temperature of the mixture.33
The relationship between Tg, carbohydrate, pH of formula-
tion, temperature of storage, physical appearance, and the
degree of chemical modification observed is summarized in
Figure 5. The observed physical structure of the freeze-dried
formulations after incubation at elevated temperatures (Table
1) were directly related to the changing material properties of
these amorphous materials as they were heated through their
glass transitions (Table 2 and Figure 5A). At temperatures in
excess of Tg, the materials transform from a solid-like glass to
a highly viscous liquid. The viscosity of the liquid decreases
rapidly with increasing temperature such that within 10C of
Tg the material is sufficiently soft for surface tension to cause
the initially porous low density structure to rapidly collapse,
losing much of its porosity and forming a compact high den-
sity liquid structure.34 This collapse is a kinetic process, its
rate predicted to be proportional to the viscosity of the liquid
phase.35 With prolonged storage, as in the 16 month incuba-
tion at 37C, the collapse effect is observed at temperatures in
the region of the glass transition itself as is observed for the
sucrose pH 6.2 formulation (Table 1).
There have been a number of studies that have investi-
gated the effect of different buffer formulations on protein
integrity, however, in most cases overall changes in second-
ary structure have been studied using techniques such as
FTIR but detailed studies of any chemical modifications are
rare. Also, the linking of formulation to activity is not com-
mon.5,11,36 There was an obvious change in lytic activity
only in those lysozyme samples formulated in pH 6.2 buffer
and heated for 24 h at 90C (Table 2). However, here we
have shown that while changes in activity are not always
measurable (Table 2), there may be chemical modification to
the protein (Table 3) occurring that could potentially lead to
changes in the antigenicity of the protein.
We note that both chemical and physical variables affect
the rate and extent of protein modifications in accelerated
thermal stability tests of freeze-dried formulations. While the
effects of some of the chemical and physical variables can
be distinguished, others could not be due to the variables
being correlated. The chemical variable is the nature of the
excipient (sucrose, trehalose, dextran) and the physical varia-
bles are temperature, pH (prior to freeze-drying) and the
physical state of the formulation (nonglassy/glassy, viscosity,
etc.). While the effect of the change in pH on the rate of
Figure 4. Reversed-phase HPLC separation of the tryptic pep-
tides of lysozyme formulated (A) sucrose at pH 6.2
before freeze-drying and storage at 558C for 1
month, (B) sucrose at pH 8.2 before freeze-drying
and storage at 558C for 1 month, and (C) trehalose
at pH 6.2 before freeze-drying and storage at 558C
for 1 month.
The peptides are labeled to correspond to the peaks and assign-
ments listed in Table 4. Deamidation modifications are depicted
with a star (*).
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protein modification may be causal, another factor to be con-
sidered is the physical state of the formulations. The 3% su-
crose pH 6.2 formulation has a glass transition temperature
of 37.7C and so this system is in the vicinity of the glass
transition at 37C and in a viscous liquid state at 55 and
90C and this is the system which reacts most extensively.
Several of the glassy systems (sucrose at pH 7.2 and 8.2 and
trehalose at pH 6.2 and 7.2) show more limited reaction
(Tables 3, 4 and Figure 5B). For the sucrose formulations
the pH variable is correlated with the changing physical
state, for example at 55C as the pH increases from 6.2 to
8.2 the systems state changes from a viscous liquid state (pH
6.2, Tg 37.7
C) to a glass (pH 7.2, Tg 75.4C and pH 8.2, Tg
87.3C). However, although the chief chemical modification
observed (glycation) was more abundant in the sucrose sam-
ple formulated at pH 6.2 at temperatures when it would no
longer be expected to be glassy, modification was clearly
occurring in sucrose and trehalose samples that were in the
glassy state (Figure 5B).
Although deamidation was detected across most of the
formulations and variables investigated (Table 4), the most
prominent modification was protein glycation. Glycation
results from reaction with glucose and/or fructose which in
the formulations investigated here is the product of degrada-
tion of the carbohydrate excipients. The degradation process
generating the reducing sugars depends upon the nature of
the excipient, temperature and pH such that the levels of
reducing sugar generated followed the trend sucrose[ treha-
lose [ dextran. We note that pH directly affects the rate of
glycation as it changes both the rate of sucrose hydrolysis
and the nucleophilicity of lysine residues. On this basis of
the extent of glycation in our formulations follows from the
concentration of reducing sugars present. In addition to the
identity of the carbohydrate excipient the protein modifica-
tions vary with the pH of the formulations. For both the su-
crose and the trehalose formulations the extent of protein
modification, as shown from the results of the LC-MS of the
intact lysozyme (e.g. Table 3) and the peptide mapping (e.g.
Table 4), increase as the pH decreases from 8.2 through 7.2
to 6.2. At 55C, the trend occurs for both the trehalose for-
mulations which are all in a solid glassy state and for the su-
crose formulations which are glassy at pH 8.2 and 7.2 and
are in a viscous liquid state at pH 6.2.
The peptide mapping results shown in Table 4 reveal that
the glycation of lysine residues varies with site although all
six residues are glycated under at least one of the conditions
investigated. Although it is difficult to precisely determine the
different lysine reactivities from this data, lysines 1 and 97
appear to be the least reactive under the conditions investi-
gated whilst lysine 33 appears to be the most such that the
reactivity varies in the order K33[K13, K116, K96[K1, K97.
Although reactions of K1 and K97 occurred solely in the liquid
pH 6.2 sucrose formulations, the other residues showed reac-
tion in the glass state. Lysine residue K33 is presumably the
most reactive with glycation occurring at this site preferen-
tially in the trehalose formulations. This order differs from
that previously reported for lysine glycation of lysozyme in
solution whereby K97 was the most reactive. Further, K97 is
part of a di-lysine motif and it is generally accepted that these
are more susceptible to glycation due to local acid–base catal-
ysis making one residue more nucelophilic.36 The fact that
K97 was least reactive in the freeze-dried samples investigated
here suggests that the local structural environment, accessibil-
ity, and charge of the lysine residues is different to that found
in solution and crystal forms. Further studies to elucidate such
differences between the solution and glassy state are therefore
required and we note that previous studies in solution using
peptide models have shown that the local environment does
influence the rate of glycation and local secondary structure
elements on glycation.37
Conclusions
Considering all the data together, we have described the
characterization of two aspects of stability, chemical stability
characterized using mass spectrometry, and the maintenance
of biological activity characterized using an enzyme activity
assay. We have studied these, both above and below the
glass transition of initially amorphous formulations. Perhaps
most importantly, we have identified that the rate of protein
modification and preferential sites for reaction differ between
the solution and glassy state, at least for nonenzymatic gly-
cation. This has implications for predicting likely protein
modifications, and sites thereof, to proteins in the glassy
state from data previously gathered in the solution state. Fur-
ther, although dextran formulated samples appeared to be the
most stable by our criteria, practically these samples were
difficult to resolubilized/reconstitute, which often took sev-
eral hours rendering them impractical commercially. There
were also clear trends between protein modification and
buffer pH prior to freeze-drying and the primary modifica-
tion detected, glycation, however the differences in the appa-
rent reactivities of the lysine residues for glycation after
freeze-drying compared with those previously determined in
solution has clear implications for the prediction of potential
Figure 5. The relationship between the carbohydrate excipient
(sucrose, trehalose or dextran), storage condition
(37oC for 16 months, 55oC for 1 month, 90oC for 24
h), glass transition (Tg) and (A) physical appearance
of samples, and (B) degree of glycation observed.
The physical appearance and degree of glycation are most
obviously affected in samples above the Tg, however modifica-
tion and changes to the physical appearance were observed in
both sucrose and trehalose samples below the Tg indicative of
changes occurring in the glass. For further details see text.
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modifications in the glassy state. Further, we predict that
whilst the relationship between formulation variables, Tg and
the physical attributes of proteins in the glassy state is likely
to hold for the majority of proteins, that the relationship
between formulation variables and chemical modification
will change as a result of the different environments that
individual amino acids experience on freeze-drying.
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